Carcinoembryonic antigen in serum in diseases of the liver and pancreas - PubMed (original) (raw)

Carcinoembryonic antigen in serum in diseases of the liver and pancreas

S K Khoo et al. J Clin Pathol. 1973 Jul.

Abstract

Carcinoembryonic antigen (CEA) was measured in whole serum and in serum extracted with perchloric acid by microradioimmunoassay in patients with benign and malignant diseases of the liver and pancreas. The level of detectability was 5 ng per ml. This level or greater was present in the serum of 50% of patients with chronic diffuse liver disease, 64% with pancreatitis, 94% with cancer of the digestive system, and 3% of controls. The incidence of levels of CEA of 5 ng/ml or more differed for various categories of chronic liver disease: from 22% in active chronic hepatitis, 46% in primary biliary cirrhosis, 63% in hepatoma, 78% in cryptogenic cirrhosis, and 88% in alcoholic cirrhosis; levels of CEA correlated with degrees of impairment of liver function as judged by bromsulphalein retention and serum levels of alkaline phosphatase and transaminase. In pancreatitis, 64% of cases had levels of CEA ranging from 5 to 20 ng/ml and in cancer of the pancreas 94% had levels above 5 ng/ml and 50% above 20 ng/ml.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Immunol Commun. 1972;1(1):11-24 - PubMed
    1. J Exp Med. 1965 Sep 1;122(3):467-81 - PubMed
    1. Cancer Res. 1968 Jul;28(7):1331-4 - PubMed
    1. Proc Natl Acad Sci U S A. 1969 Sep;64(1):161-7 - PubMed
    1. Am J Dig Dis. 1971 Jan;16(1):1-7 - PubMed

MeSH terms

Substances

LinkOut - more resources